Nonoinc preview
Nonoinc favicon

Nonoinc Review

May 2026

$18M
Revenue
117
Employees
30%
Growth
Estimated Revenue
$18M
Total Employees
117
Employee Growth
30%
Industry
Biotech
Location
Toronto, CAN
About

NoNO Inc. Announces the Start of the Global Phase 3 ESCAPE-NEXT Trial of the Peptide Nerinetide in Acute Ischemic Stroke Excluding Thrombolysis

Global Rank
N/A

What is Nonoinc's Revenue?

Nonoinc's estimated revenue is $18M.

What does Nonoinc do?

NoNO Inc. Announces the Start of the Global Phase 3 ESCAPE-NEXT Trial of the Peptide Nerinetide in Acute Ischemic Stroke Excluding Thrombolysis

CompanyRevenueEmployeesGrowthFunding
CeragenCeragen
$4.2M2729.4%$5M
Paradox ImmunotherapeuticsParadox Immunotherapeutics
$1.7M1128.6%N/A
Tetra Bio-PharmaTetra Bio-Pharma
$0.9M11-71.9%$39.4M
CyclicaCyclica
$1.0M13-83.1%$23.8M
SemexSemex
$94.4M6097.8%N/A
TREVENTIS CorporationTREVENTIS Corporation
$3.4M2212.5%N/A
Spartan BioscienceSpartan Bioscience
$9.5M61-68.0%N/A
NoNONoNO
$18.1M11729.7%N/A
MicrobixMicrobix
$21.7M140-5.7%N/A
Mannin ResearchMannin Research
$1.0M13-38.9%N/A
📊Analytics & Marketing1
📝CMS1
🎯CSS Frameworks2
🔧Customer Support1
🔧Fonts1
🎨JavaScript Libraries4
🔧Media1
🔧Programming Languages1
🎯UI Libraries1
🔧Web Standards2
Tracking & Analytics4
G
Google Analytics
G
Google Tag Manager
G
Google APIs
G
Google Analytics

Technology detection powered by advanced web analysis

Powered byTechlist.ai